Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIVO Device in Soft Tissue Sarcoma
NCT03056599Phase 1Completed
- Sponsor
- Presage Biosciences
- Start
- Dec 2016
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Presage Biosciences. Primary endpoint: Quantification of fraction of cells positive for apoptosis and drug target engagement biomarkers around injected drugs. Started Dec 2016; status: completed.
Beyond the preview
Go deeper on NCT03056599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03056599.